Markets:

Overview

News

Currencies

International

Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

23.09 +0.41 (+1.81%)

Streaming Delayed Price Updated: 2:28 PM EST, Jan 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Apple, Amazon, HP And Other Big Losers From Friday ↗

August 29, 2022

U.S. stocks closed sharply lower with the Dow Jones tumbling more than 1,000 points on Friday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday ↗

August 29, 2022

Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2022 ↗

August 18, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About 10x Genomics ↗

August 10, 2022

Within the last quarter, 10x Genomics (NASDAQ:TXG) has observed the following analyst ratings:

Via Benzinga

10x Genomics: Q2 Earnings Insights ↗

August 08, 2022

10x Genomics (NASDAQ:TXG) reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

What 5 Analyst Ratings Have To Say About 10x Genomics ↗

July 15, 2022

Within the last quarter, 10x Genomics (NASDAQ:TXG) has observed the following analyst ratings:

Via Benzinga

10X Genomics Reports Q2 Preliminary Revenues, Shares Plummet On Missing Street Expectation ↗

July 14, 2022

Via Benzinga

10x Genomics: Q1 Earnings Insights ↗

May 12, 2022

10x Genomics (NASDAQ:TXG) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For August 8, 2022 ↗

August 08, 2022

Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 11, 2022

On Wednesday, 807 companies reached new 52-week lows.

Via Benzinga

4 Analysts Have This to Say About 10x Genomics ↗

May 06, 2022

Analysts have provided the following ratings for 10x Genomics (NASDAQ:TXG) within the last quarter:

Via Benzinga

10x Genomics Posts Topline Growth Of 8%, Reaffirms FY22 Guidance ↗

May 05, 2022

10x Genomics (NASDAQ: TXG) reported

Via Benzinga

Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday ↗

July 18, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering...

Via Benzinga

Barron's Stock Spotlight: Spirit Airlines, Rivian, UnitedHealth And This Genomics Company ↗

July 16, 2022

Benzinga reviews this weekend's top stories on Barron's, for additional information on the latest market news, Benzinga Pro offers a 24/7 news feed, live chat and charting software.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 15, 2022

Via Benzinga

Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session ↗

July 15, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 15, 2022

On Friday, 137 stocks made new 52-week lows.

Via Benzinga

Why This 10X Genomics Analyst Is Turning Bearish, Slashing Price Target ↗

July 15, 2022

10X Genomics Inc (NASDAQ: TXG) reported preliminary second-quarter revenues Thursday that were meaningfully below the consensus estimates.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022 ↗

July 15, 2022

Via Benzinga

Why U.S. Stocks Are Trading Higher; Retail Sales Rise This Much In June ↗

July 15, 2022

U.S. stocks traded higher this morning, following the release of several earnings results and economic reports.

Via Benzinga

10x Genomics Crashes On Sales Disappointment, Extending A Yearlong Selloff ↗

July 15, 2022

Preliminarily, the company expects a second-quarter sales decline, the first in two years.

Via Investor's Business Daily

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 15, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 15, 2022

Good morning! We're starting the last day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Why Is Pinterest Higher By 14%? 20 Stocks Moving In Friday's Pre-Market Session ↗

July 15, 2022

Gainers United Maritime Corporation (NASDAQ: USEA) rose 55% to $3.41 in pre-market trading. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on...

Via Benzinga

7 Stocks to Buy That Could Make You a Millionaire ↗

June 23, 2022

These seven of the best stocks to buy in June. TXG, BRKR, ETSY, PODD, MAR, RH and SEDG can make excellent investments.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Monday ↗

June 13, 2022

During Monday's trading, 1214 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 14, 2022

On Tuesday, 951 companies hit new 52-week lows.

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

10x Genomics: Q1 Earnings Insights ↗

May 04, 2022

10x Genomics (NASDAQ:TXG) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings 10x Genomics missed estimated...

Via Benzinga

Earnings Scheduled For May 4, 2022 ↗

May 04, 2022

Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.